Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,746 public trials 1,052 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • City of Hope Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Irvine, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT04267848

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 1151 locations
View Trial Details
Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

NCT07361497

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Local Institution - 0780 Chandler, Arizona, United States
  • Intermountain Health Cancer Center Lutheran Hospital Golden, Colorado, United States
  • Medical Oncology Hematology Consultants, PA Newark, Delaware, United States
View all 259 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06793215

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • Marin Cancer Care Inc Greenbrae, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 280 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06568939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center /ID# 276370 Chandler, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 272923 Little Rock, Arkansas, United States
  • Valkyrie Clinical Trials /ID# 271322 Los Angeles, California, United States
  • Yale New Haven Hospital /ID# 271584 New Haven, Connecticut, United States
View all 80 locations
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

NCT07361510

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Mohtaseb Cancer Center & Blood Disorders Bullhead City, Arizona, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Orange Coast Memorial Medical Center Fountain Valley, California, United States
View all 279 locations
View Trial Details
Recruiting

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

NCT06862869

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China
  • Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou, China
  • Huai He Hospital of Henan University Kaifeng, Henan, China
  • Henan Provincial Chest Hospital Zhengzhou, Henan, China
View all 44 locations
View Trial Details

Related conditions